查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1661075

2025 年至 2033 年按癌症类型（非小细胞肺癌 (NSCLC)、小细胞肺癌 (SCLC)）、标记类型（EGFR、EML4-ALK、KRAS、BRAF 等）、最终用户（医院、诊断实验室等）和地区分類的肺标记市场报告

Lung Marker Market Report by Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Marker Type (EGFR, EML4-ALK, KRAS, BRAF, and Others), End User (Hospitals, Diagnostic Labs, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024IMARC Group全球肺标记市场规模达到 4.822 亿美元。

一般而言，在肺部介入治疗或肺部手术及诊断中，主要使用EGFR、EML4-ALK、KRAS、BRAF四大类肺部标记。此外，这些标记物也用于检测、诊断、预测和监测肿瘤，并据此为患者制定治疗方案。肺标记仅可与多种影像学检查和活检一起作为识别癌症的辅助工具。因此，肺部标记广泛应用于各大医院、门诊手术诊所、专科诊所和其他几家医疗机构的胸腔镜手术。

肺部标记需求的不断增长，可归因于全球空气污染水平不断上升，导致胸腔积液、胸膜间皮瘤、胸膜斑等呼吸系统疾病盛行率不断上升。除此之外，大量被动吸烟以及有肺癌家族史进一步增加了肺癌患者的数量，从而增加了对肺部标记的需求。此外，老年人口的激增，以及忙碌的生活方式导致的吸烟率高，进一步加速了多种呼吸系统疾病的风险。除此之外，各国政府对肺癌等危及生命的疾病的早期诊断和预治疗的医疗保健支出不断增加，也推动了全球范围内肺部标誌物的使用率不断上升。此外，对肺癌诊断和治疗领域的多项研发活动的投资不断增加，进一步刺激了对肺部标记的需求。除此之外，医院、外科中心、诊所中肺部标记的使用日益增多以及其在治疗目的中的各种应用也催化了产品需求。

本报告回答的关键问题：

  • 到目前为止，全球肺标记市场表现如何，未来几年将如何表现？
  • COVID-19 对全球肺部标记市场有何影响？
  • 主要的区域市场有哪些？
  • 根据癌症类型，市场分布如何？
  • 根据标记类型，市场如何划分？
  • 根据最终用户，市场分布如何？
  • 该产业的价值链分为哪些阶段？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球肺标记市场的结构是怎样的？
  • 产业的竞争程度如何？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球肺标记市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依癌症类型

  • 非小细胞肺癌（NSCLC）
    • 市场趋势
    • 市场预测
  • 小细胞肺癌 (SCLC)
    • 市场趋势
    • 市场预测

第七章：市场区隔：依市场类型

  • 表皮生长因子受体
    • 市场趋势
    • 市场预测
  • EML4基因
    • 市场趋势
    • 市场预测
  • 克拉斯
    • 市场趋势
    • 市场预测
  • BRAF
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 诊断实验室
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他的
  • 中东和非洲
    • 土耳其
    • 伊朗
    • 其他的

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格指标

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc
    • Agilent Technologies, Inc.
    • Beckman Coulter, Inc.
    • Fujirebio Europe NV
    • Hologic, Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • BioSpace, Inc.
Product Code: SR112025A2063

The global lung marker market size reached USD 482.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,104.6 Million by 2033, exhibiting a growth rate (CAGR) of 9.6% during 2025-2033.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

Breakup by Cancer Type:

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

  • EGFR
  • EML4-ALK
  • KRAS
  • BRAF
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Labs
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Others
  • Middle East and Africa
  • Turkey
  • Iran
  • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Lung Marker Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact Of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Non-Small Cell Lung Cancer (NSCLC)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Cell Lung Cancer (SCLC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Marker Type

  • 7.1 EGFR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 EML4-ALK
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 KRAS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 BRAF
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Japan
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 India
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 South Korea
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Australia
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Argentina
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
    • 9.4.4 Colombia
      • 9.4.4.1 Market Trends
      • 9.4.4.2 Market Forecast
    • 9.4.5 Chile
      • 9.4.5.1 Market Trends
      • 9.4.5.2 Market Forecast
    • 9.4.6 Peru
      • 9.4.6.1 Market Trends
      • 9.4.6.2 Market Forecast
    • 9.4.7 Others
      • 9.4.7.1 Market Trends
      • 9.4.7.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Turkey
      • 9.5.1.1 Market Trends
      • 9.5.1.2 Market Forecast
    • 9.5.2 Iran
      • 9.5.2.1 Market Trends
      • 9.5.2.2 Market Forecast
    • 9.5.3 Others
      • 9.5.3.1 Market Trends
      • 9.5.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Thermo Fisher Scientific Inc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agilent Technologies, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fujirebio Europe N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hologic, Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Siemens Healthineers
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 BioSpace, Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Lung Marker Market: Major Drivers and Challenges
  • Figure 2: Global: Lung Marker Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2024
  • Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2024
  • Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Turkey: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Iran: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Argentina: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Colombia: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Chile: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Peru: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Others: Lung Marker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Lung Marker Industry: SWOT Analysis
  • Figure 91: Global: Lung Marker Industry: Value Chain Analysis
  • Figure 92: Global: Lung Marker Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Lung Marker Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million USD), 2025-2033
  • Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million USD), 2025-2033
  • Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Lung Marker Market: Competitive Structure
  • Table 7: Global: Lung Marker Market: Key Players